By Adam Lidgett ( March 29, 2022, 7:15 PM EDT) -- The U.S. Food and Drug Administration said Tuesday that it was approving a second booster dose of the Pfizer-BioNTech and Moderna vaccines for certain populations, in the wake of new data suggesting the efficacy of COVID-19 vaccines can diminish as time wears on....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.